ANI Pharmaceuticals, Inc. (BST:BSFA)

ANI Pharmaceuticals Statistics

Total Valuation

BST:BSFA has a market cap or net worth of EUR 1.37 billion. The enterprise value is 1.67 billion.

Market Cap	1.37B
Enterprise Value	1.67B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.90M
Shares Outstanding	n/a
Shares Change (YoY)	+9.89%
Shares Change (QoQ)	+3.23%
Owned by Insiders (%)	6.94%
Owned by Institutions (%)	107.51%
Float	19.01M

Valuation Ratios

The trailing PE ratio is 20.80 and the forward PE ratio is 8.68.

PE Ratio	20.80
Forward PE	8.68
PS Ratio	1.82
PB Ratio	2.97
P/TBV Ratio	n/a
P/FCF Ratio	9.37
P/OCF Ratio	8.67
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.43, with an EV/FCF ratio of 11.46.

EV / Earnings	25.44
EV / Sales	2.23
EV / EBITDA	11.43
EV / EBIT	24.29
EV / FCF	11.46

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 1.14.

Current Ratio	2.71
Quick Ratio	2.07
Debt / Equity	1.14
Debt / EBITDA	3.57
Debt / FCF	3.60
Interest Coverage	4.05

Financial Efficiency

Return on equity (ROE) is 16.16% and return on invested capital (ROIC) is 7.68%.

Return on Equity (ROE)	16.16%
Return on Assets (ROA)	3.73%
Return on Invested Capital (ROIC)	7.68%
Return on Capital Employed (ROCE)	6.99%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	838,755
Profits Per Employee	73,282
Employee Count	897
Asset Turnover	0.65
Inventory Turnover	2.44

Taxes

In the past 12 months, BST:BSFA has paid 14.87 million in taxes.

Income Tax	14.87M
Effective Tax Rate	18.22%

Stock Price Statistics

The stock price has increased by +27.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.45%
50-Day Moving Average	68.00
200-Day Moving Average	67.42
Relative Strength Index (RSI)	44.16
Average Volume (20 Days)	7

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BST:BSFA had revenue of EUR 752.36 million and earned 65.73 million in profits. Earnings per share was 2.83.

Revenue	752.36M
Gross Profit	461.67M
Operating Income	69.18M
Pretax Income	81.59M
Net Income	65.73M
EBITDA	147.04M
EBIT	69.18M
Earnings Per Share (EPS)	2.83

Balance Sheet

The company has 251.01 million in cash and 525.53 million in debt, with a net cash position of -274.52 million.

Cash & Cash Equivalents	251.01M
Total Debt	525.53M
Net Cash	-274.52M
Net Cash Per Share	n/a
Equity (Book Value)	460.53M
Book Value Per Share	20.48
Working Capital	404.56M

Cash Flow

In the last 12 months, operating cash flow was 157.76 million and capital expenditures -11.78 million, giving a free cash flow of 145.97 million.

Operating Cash Flow	157.76M
Capital Expenditures	-11.78M
Free Cash Flow	145.97M
FCF Per Share	n/a

Margins

Gross margin is 61.36%, with operating and profit margins of 9.20% and 8.87%.

Gross Margin	61.36%
Operating Margin	9.20%
Pretax Margin	10.84%
Profit Margin	8.87%
EBITDA Margin	19.54%
EBIT Margin	9.20%
FCF Margin	19.40%

Dividends & Yields

BST:BSFA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	1.48%
Buyback Yield	-9.89%
Shareholder Yield	-9.89%
Earnings Yield	4.81%
FCF Yield	10.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6